• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌 III 型分泌系统水杨醛酰腙抑制剂的临床前药代动力学和抗衣原体活性。

Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion.

机构信息

Department of Chemistry, Umeå University, Sweden.

出版信息

J Antibiot (Tokyo). 2012 Aug;65(8):397-404. doi: 10.1038/ja.2012.43. Epub 2012 Jun 6.

DOI:10.1038/ja.2012.43
PMID:22669447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3428607/
Abstract

Salicylidene acylhydrazides belong to a class of compounds shown to inhibit bacterial type III secretion (T3S) in pathogenic Gram-negative bacteria. This class of compounds also inhibits growth and replication of Chlamydiae, strict intracellular bacteria that possess a T3S system. In this study a library of 58 salicylidene acylhydrazides was screened to identify inhibitors of Chlamydia growth. Compounds inhibiting growth of both Chlamydia trachomatis and Chlamydophila pneumoniae were tested for cell toxicity and seven compounds were selected for preliminary pharmacokinetic analysis in mice using cassette dosing. Two compounds, ME0177 and ME0192, were further investigated by individual pharmacokinetic analysis. Compound ME0177 had a relatively high peak plasma concentration (C(max)) and area under curve and therefore may be considered for systemic treatment of Chlamydia infections. The other compound, ME0192, had poor pharmacokinetic properties but the highest anti-chlamydial activity in vitro and therefore was tested for topical treatment in a mouse vaginal infection model. ME0192 administered vaginally significantly reduced the infectious burden of C. trachomatis and the number of infected mice.

摘要

水杨醛酰腙类化合物属于一类被证明能抑制致病性革兰氏阴性菌的 III 型分泌系统(T3S)的化合物。这类化合物还能抑制衣原体的生长和复制,而衣原体是一种严格的细胞内细菌,具有 T3S 系统。在这项研究中,筛选了一个 58 种水杨醛酰腙的文库,以鉴定抑制衣原体生长的抑制剂。对同时抑制沙眼衣原体和肺炎衣原体生长的化合物进行了细胞毒性测试,并选择了 7 种化合物进行小鼠体内药代动力学分析,采用盒式给药。两种化合物 ME0177 和 ME0192 进一步进行了个体药代动力学分析。化合物 ME0177 具有相对较高的血浆峰浓度(C(max))和曲线下面积,因此可能被考虑用于系统治疗衣原体感染。另一种化合物 ME0192 的药代动力学特性较差,但在体外具有最高的抗衣原体活性,因此在小鼠阴道感染模型中测试了其局部治疗效果。阴道给予 ME0192 可显著降低沙眼衣原体的感染负荷和感染小鼠的数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/3428607/e984456df4a6/ja201243f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/3428607/4619d17562b3/ja201243f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/3428607/2d39ae140c57/ja201243f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/3428607/e984456df4a6/ja201243f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/3428607/4619d17562b3/ja201243f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/3428607/2d39ae140c57/ja201243f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c748/3428607/e984456df4a6/ja201243f3.jpg

相似文献

1
Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion.细菌 III 型分泌系统水杨醛酰腙抑制剂的临床前药代动力学和抗衣原体活性。
J Antibiot (Tokyo). 2012 Aug;65(8):397-404. doi: 10.1038/ja.2012.43. Epub 2012 Jun 6.
2
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia.基于统计的水杨醛酰腙类化合物库的靶向设计及革兰氏阴性菌耶尔森氏菌 III 型分泌系统抑制的多元定量构效关系研究
Bioorg Med Chem. 2010 Apr 1;18(7):2686-703. doi: 10.1016/j.bmc.2010.02.022. Epub 2010 Feb 18.
3
Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis.五味子属植物中的二苯并环辛二烯木脂素可选择性抑制细胞内细菌肺炎衣原体和沙眼衣原体的生长。
J Antibiot (Tokyo). 2015 Oct;68(10):609-14. doi: 10.1038/ja.2015.48. Epub 2015 May 6.
4
Comparative in vitro activity of garenoxacin against Chlamydia spp.加替沙星对衣原体属的体外活性比较
J Antimicrob Chemother. 2002 Sep;50(3):407-10. doi: 10.1093/jac/dkf145.
5
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.候选阴道杀菌剂对沙眼衣原体和淋病奈瑟菌有效。
Int J Antimicrob Agents. 2010 Aug;36(2):145-50. doi: 10.1016/j.ijantimicag.2010.03.018. Epub 2010 Jun 1.
6
Treatment of Chlamydial infections: 2014 update.衣原体感染的治疗:2014年更新版。
Expert Opin Pharmacother. 2015 Feb;16(2):205-12. doi: 10.1517/14656566.2015.999041.
7
In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.GAR-936对肺炎衣原体和沙眼衣原体的体外活性。
Int J Antimicrob Agents. 2000 Sep;16(1):61-3. doi: 10.1016/s0924-8579(00)00198-9.
8
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.新型氟喹诺酮类抗生素 CEM-101 对沙眼衣原体和肺炎衣原体(衣原体属)的体外活性。
Antimicrob Agents Chemother. 2010 Mar;54(3):1358-9. doi: 10.1128/AAC.01343-09. Epub 2009 Dec 28.
9
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.新型DNA旋转酶抑制剂AZD0914对沙眼衣原体和肺炎衣原体的体外活性
Antimicrob Agents Chemother. 2014 Dec;58(12):7595-6. doi: 10.1128/AAC.03920-14. Epub 2014 Oct 6.
10
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.新型二氨基嘧啶化合物伊克拉普对沙眼衣原体和肺炎衣原体的体外活性
Antimicrob Agents Chemother. 2004 May;48(5):1885-6. doi: 10.1128/AAC.48.5.1885-1886.2004.

引用本文的文献

1
A multi-strategy antimicrobial discovery approach reveals new ways to treat Chlamydia.一种多策略抗菌发现方法揭示了治疗衣原体的新途径。
PLoS Biol. 2025 Apr 29;23(4):e3003123. doi: 10.1371/journal.pbio.3003123. eCollection 2025 Apr.
2
Type III Secretion in .III 型分泌系统在... 中。
Microbiol Mol Biol Rev. 2023 Sep 26;87(3):e0003423. doi: 10.1128/mmbr.00034-23. Epub 2023 Jun 26.
3
Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems.通过抑制与毒力相关的 III 型和 IV 型分泌系统来靶向细菌发病机制。

本文引用的文献

1
Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide.使用一种可能的杀微生物剂柳氮乙酰腙,保护小鼠免受沙眼衣原体阴道感染。
J Infect Dis. 2011 Nov;204(9):1313-20. doi: 10.1093/infdis/jir552. Epub 2011 Sep 20.
2
Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds.鉴定水杨酰腙类毒力阻断化合物的细菌靶蛋白。
J Biol Chem. 2011 Aug 26;286(34):29922-31. doi: 10.1074/jbc.M111.233858. Epub 2011 Jul 1.
3
Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
Front Cell Infect Microbiol. 2023 Jan 10;12:1065561. doi: 10.3389/fcimb.2022.1065561. eCollection 2022.
4
Alternative strategies for treatment: Promising non-antibiotic approaches.治疗的替代策略:有前景的非抗生素方法。
Front Microbiol. 2022 Nov 23;13:987662. doi: 10.3389/fmicb.2022.987662. eCollection 2022.
5
Five Plant Natural Products Are Potential Type III Secretion System Inhibitors to Effectively Control Soft-Rot Disease Caused by .五种植物天然产物是潜在的III型分泌系统抑制剂,可有效控制由……引起的软腐病。
Front Microbiol. 2022 Feb 22;13:839025. doi: 10.3389/fmicb.2022.839025. eCollection 2022.
6
Tannic Acid Inhibits Serovar Typhimurium Infection by Targeting the Type III Secretion System.单宁酸通过靶向Ⅲ型分泌系统抑制鼠伤寒血清型沙门氏菌感染。
Front Microbiol. 2022 Jan 25;12:784926. doi: 10.3389/fmicb.2021.784926. eCollection 2021.
7
Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components.抑制细菌 III 型分泌系统(T3SS)的分子靶点和策略;直接结合 T3SS 成分的抑制剂。
Biomolecules. 2021 Feb 19;11(2):316. doi: 10.3390/biom11020316.
8
Liposomes-In-Hydrogel Delivery System Enhances the Potential of Resveratrol in Combating Vaginal Chlamydia Infection.水凝胶包裹脂质体递送系统增强白藜芦醇对抗阴道衣原体感染的潜力。
Pharmaceutics. 2020 Dec 11;12(12):1203. doi: 10.3390/pharmaceutics12121203.
9
The Putative Type III Secreted Virulence-Associated Protein CAB063 Targets Lamin and Induces Apoptosis.假定的III型分泌的毒力相关蛋白CAB063作用于核纤层蛋白并诱导细胞凋亡。
Front Microbiol. 2020 May 25;11:1059. doi: 10.3389/fmicb.2020.01059. eCollection 2020.
10
Inhibition of the type III secretion system by syringaldehyde protects mice from Salmonella enterica serovar Typhimurium.丁香醛抑制 III 型分泌系统可保护小鼠免受鼠伤寒沙门氏菌侵袭。
J Cell Mol Med. 2019 Jul;23(7):4679-4688. doi: 10.1111/jcmm.14354. Epub 2019 May 8.
对阿奇霉素敏感性降低的沙眼衣原体临床分离株中,大环内酯类耐药基因未发生突变。
Int J Antimicrob Agents. 2011 Aug;38(2):178-9. doi: 10.1016/j.ijantimicag.2011.03.015. Epub 2011 May 13.
4
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.候选阴道杀菌剂对沙眼衣原体和淋病奈瑟菌有效。
Int J Antimicrob Agents. 2010 Aug;36(2):145-50. doi: 10.1016/j.ijantimicag.2010.03.018. Epub 2010 Jun 1.
5
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia.基于统计的水杨醛酰腙类化合物库的靶向设计及革兰氏阴性菌耶尔森氏菌 III 型分泌系统抑制的多元定量构效关系研究
Bioorg Med Chem. 2010 Apr 1;18(7):2686-703. doi: 10.1016/j.bmc.2010.02.022. Epub 2010 Feb 18.
6
Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic/pharmacodynamic indices.组织分布在解读抗感染药动学/药效学指标中的类别相关性。
Int J Antimicrob Agents. 2010 May;35(5):431-8. doi: 10.1016/j.ijantimicag.2010.01.023.
7
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.PKSolver:一个在 Microsoft Excel 中进行药代动力学和药效动力学数据分析的插件程序。
Comput Methods Programs Biomed. 2010 Sep;99(3):306-14. doi: 10.1016/j.cmpb.2010.01.007. Epub 2010 Feb 21.
8
Antivirulence drugs to target bacterial secretion systems.抗细菌分泌系统的抗病毒药物。
Curr Opin Microbiol. 2010 Feb;13(1):100-5. doi: 10.1016/j.mib.2009.12.003. Epub 2010 Jan 14.
9
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.新型氟喹诺酮类抗生素 CEM-101 对沙眼衣原体和肺炎衣原体(衣原体属)的体外活性。
Antimicrob Agents Chemother. 2010 Mar;54(3):1358-9. doi: 10.1128/AAC.01343-09. Epub 2009 Dec 28.
10
Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7.水杨醛酰肼化合物对大肠杆菌O157:H7Ⅲ型分泌作用的表征
Infect Immun. 2009 Oct;77(10):4209-20. doi: 10.1128/IAI.00562-09. Epub 2009 Jul 27.